Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
Alex Brill Writes to FTC Regarding Interim Pharmacy Benefit Manager Report

Alex Brill Writes to FTC Regarding Interim Pharmacy Benefit Manager Report

Aug 1, 2024 | Analysis

In July, MGA CEO Alex Brill submitted a comment letter to the Federal Trade Commission (FTC) expressing concerns about their newly released interim report.

New MGA Analysis Finds Drug Rebates Not Associated with List Price Increases

New MGA Analysis Finds Drug Rebates Not Associated with List Price Increases

Jan 10, 2024 | Analysis

In a new report, MGA examines the role of rebates among a subset of prescription drugs with the biggest price hikes between 2018 and 2023. 

The Threat to Preferred Pharmacy Networks

The Threat to Preferred Pharmacy Networks

Jan 8, 2024 | Commentary

Provider networks are a well-known tool health insurance companies use to keep down the cost of care.

Alex Brill Speaks on Consequences of Proposed PBM Constraints

Alex Brill Speaks on Consequences of Proposed PBM Constraints

Dec 14, 2023 | Events

In December, MGA CEO Alex Brill participated in a RealClearPolitics event looking at the negative consequences of limiting the business practices of PBMs.

Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded

Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded

May 12, 2022 | Analysis

In response to the FTC’s request for information regarding the business practices of pharmacy benefit managers (PBMs) and their impact on pharmacies and consumers, MGA’s Alex Brill submitted a letter detailing his findings.

  • Analysis (50)
  • Books (3)
  • Commentary (15)
  • Events (21)
  • Interviews (59)
  • News (55)
  • Op-Eds (96)
  • Press Releases (4)
  • Testimony (21)
  • effects of 304B
    The 340B Program’s Negative Impact on Pharmaceutical InnovationJune 5, 2025
  • a conversation on tax reform
    A Conversation with House Ways and Means Committee Chairman Jason Smith on Tax ReformMarch 5, 2025
  • US Biosimilars Market
    New MGA Paper Identifies Barriers to US Biosimilar Success in the Second DecadeMarch 5, 2025
  • Congress on the Brink of Disrupting the PBM Market
    Congress on the Brink of Disrupting the PBM MarketJanuary 27, 2025
  • Raising the Salt Cap Would Increase Tax Complexity
    Raising the Salt Cap Would Increase Tax ComplexityJanuary 13, 2025
  • Economics of “Delinking” Are Still Not Good
    Economics of “Delinking” Are Still Not GoodDecember 13, 2024
  • Child Tax Credit Tradeoffs
    The Child Tax Credit: Tradeoffs and PreferencesOctober 30, 2024
  • Oregon’s Measure 118 Turnover Tax
    Oregon’s Measure 118: The Turnover Tax Is the WorstOctober 29, 2024
  • Dueling Child Tax Credit Proposals
    Dueling Child Tax Credit Proposals: Harris vs. VanceOctober 21, 2024
  • Deduction for Auto Loan Interest
    Trump Proposes Bringing Back the Deduction for Auto Loan InterestOctober 16, 2024
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact